Zhongnan Medical Journal Press

Home Results

A total of 2167 result was found. Results that relate to R

Data mining research on traditional Chinese medicine formulas for epilepsy treatment based on national patents

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1220-1230.
10189 times 1855 times

HUANG Haiwen HU Jiajing ZHANG Yi CHEN Shaolan HUANG Qianqian GAO Min

Data mining Epilepsy Traditional Chinese medicine compound Medication and compatibility patterns Wind-expelling and convulsion-arresting drugs Liver-soothing and wind-extinguishing drugs Patent
Details
Data-mining of piperacillin-tazobactam related adverse drug event signals based on FAERS

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1231-1239.
10001 times 1816 times

LIU Jinwei DONG Junli SHAO Yu ZHANG Shaohui

Piperacillin tazobactam Adverse drug event FAERS database Signal mining Diseases of blood and lymphatic system Medication safety
Details
Exploring the implementation of licensed assistant pharmacist system in retail pharmacies

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1240-1247.
8202 times 1584 times

XU Long YE Hua YANG Jianwei WEN Ruirui ZHU Wenjing

Retail pharmacy Licensed assistant pharmacist Pharmacy technicians with secondary vocational education Pharmaceutical care
Details
Analysis of the factors influencing the efficacy of conventional Western medicine treatment on patients with acute exacerbation of COPD

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1248-1256.
8911 times 1620 times

GAO Xiaoxue LI Yanfei LIU Baozhu

Chronic obstructive pulmonary disease Conventional treatment Therapeutic efficacy Risk factors Individualized therapy Logistic regression
Details
Antifibrinolytic drugs used in pediatric cardiac surgery: a systematic review and Meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1257-1264.
8576 times 1408 times

WANG Qian LIANG Xingchi YANG Xinghai LIU Jun

Cardiac surgery Extracorporeal circulation Antifibrinolytic drugs Peptidase Tranexamic acid Aminocaproic acid Cardiopulmonary Hemostasis Safety
Details
Ideological and political teaching design for clinical research curriculum

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1265-1272.
9446 times 1601 times

YAN Siyu HUANG Jiao WANG Yu GUO Yi ZENG Xiantao JIN Yinghui

Clinical research Ideological and political education in curriculum Medical courses Simulation teaching Flipped classroom Problem-based learning Case-based learning Team-based learning
Details
Pharmacoeconomic evaluation of fluticasone furoate/umeclidinium/ vilanterol powder for inhalation for the treatment of chronic obstructive pulmonary disease

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):721-730.
10173 times 1900 times

DING Xueru LIU Huimin HE Xiaodong LI Hua LI Zhihao

Fluticasone furoate/umeclidinium/vilanterol Chronic obstructive pulmonary disease Markov model Cost-utility analysis Pharmacoeconomic
Details
Data mining based on the dosage pattern of Chinese herbal compound patents for the treatment of influenza

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):731-742.
11174 times 2026 times

LI Zhen HUANG Xiajin YIN Wenjing WANG Haifeng

Influenza Chinese herbal compound Patent Association rules Factor analysis Cluster analysis Medication pattern
Details
Investigation and influential factors analysis of knowledge-attitude-practice concerning medication risks among university students in Karamay

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):743-752.
9240 times 1894 times

SHI Yang CHEN Zhendong ZHANG Shengzhao TAN Xue FAN Dengfeng CHEN Xiaoli

Medication risk Knowledge-attitude-practice Karamay University students Influential factors Rational drug use
Details
Mining and analysis for ocular adverse event signals induced by ALK inhibitors based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):753-759.
9053 times 1834 times

LUO Banglong ZHOU Yanping SU Rui

ALK inhibitors FAERS database Ocular adverse events Signal mining Pharmacovigilance
Details
Study on the disease burden and prediction of substance use disorder in China based on age-period-cohort model

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):760-769.
12240 times 2105 times

BI Hui MA Danhua XU Guili HUA Yunpeng XING Liang

Drug abuse Substance use disorder Disease burden Trend analysis Age-period-cohort model
Details
Ertugliflozin in the treatment of type 2 diabetes mellitus: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):778-789.
10834 times 2011 times

QIN Fang WU Kunrong LIU Chengyu LIU Daihua

Ertugliflozin Type 2 diabetes mellitus Efficacy Safety Cost-effectiveness Rapid health technology assessment
Details
First-line treatment with tislelizumab for advanced non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):790-800.
10310 times 1786 times

LI Wenyan PAN Xiding JIE Qiong LI Yuanyuan TANG Mufei

Tislelizumab Non-small cell lung cancer First-line treatment Rapid health technology assessment
Details
Bibliometric analysis of the application of machine learning in pharmacovigilance

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):801-811.
10115 times 2108 times

LI Limin WU Wenyu WEI Fenfang Tang Biyu WU Jianru

Machine learning Pharmacovigilance Bibliometrics
Details
One case of myelosuppression caused by pamiparib in combination with temozolomide in the treatment of small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):824-829.
10603 times 1996 times

YANG Yuchen ZHAO Yuting LI Shiqi GONG Jiayu SU Riguga SUN Yanyan CAI Zhihui

Small cell lung cancer Pamiparib Temozolomide Bone marrow suppression Adverse drug reactions
Details